Investors and ministries are trying to build healthcare capacity at scale in places where clean water, reliable power and accreditation, the things finance depends on, cannot be assumed.
The infrastructure gap is enormous. Sub-Saharan Africa alone needs around 6,200 new facilities and roughly 2.5 million additional beds by 2030, against a projected shortfall of 6.1 million healthcare workers. Universal health coverage targets sit on top of a system already short of capacity.
The basics that clinical care and accreditation depend on are often absent. Only about 51% of sub-Saharan primary facilities have basic water and sanitation, and only around a third have reliable electricity. A hospital cannot control infection or hold accreditation without them.
Investment is conditional. International accreditation is scarce across the region and is the quality signal that attracts patients, and development finance is tied to standards such as the IFC Performance Standards on pollution prevention and community health. Miss the standard and the funding does not follow.
We deliver the whole facility, design, construction, equipping and management, with the water, energy and infection control that accreditation and financing require engineered in, not added later.
Reliable clean water, on-site energy and infection control effective against resistant pathogens are built into the facility from the start, so it can operate and hold accreditation in settings where the public supply cannot be relied on. That is what turns a project into a bankable, standards-compliant asset.
One accountable partner carries the technical and the local delivery, with a proven track record of international accreditation in a region where it is scarce, so investors and ministries are not assembling capability from a dozen sources against a financing deadline.
Design, construction and management aimed at international accreditation, with a proven track record of JCI accreditations and reaccreditations in a region where accreditation is scarce.
Infection control effective against antimicrobial-resistant and biofilm-forming pathogens, including independently verified removal of 99.99% of biofilm (ASTM E2799), where pathogen load is high.
Water treatment validated to bring waterborne pathogens to 0 cfu/g, confirmed by a UKAS-accredited laboratory, so clinical care does not depend on an unreliable supply.
Energy recovered and generated on site, reducing dependence on an unreliable grid, so theatres and wards keep running.
Air purification removing up to 99.9% of airborne pathogens in independent testing, with no ozone or harmful byproducts, in wards and theatres.
Built to the IFC Performance Standards on pollution prevention and community health that development finance requires, with a single accountable partner carrying technical and local delivery.
Independently verified, in the conditions that decide accreditation.
The UK environmental and safety duties that commonly reach emerging markets. Open any one for what it requires, the deadlines, what is at stake, and how to evidence control. Every entry is sourced.
The questions investors and ministries ask first are the right ones: what is the execution risk, is it affordable and sustainable for us, and does it meet the standards that finance depends on?
So we build the answer into the facility. The water, energy and infection control that accreditation and the IFC Performance Standards require are engineered in from the start, not retrofitted, and a single accountable partner carries both the technical and the local delivery. The track record of international accreditation in a region where it is scarce is the evidence the case is deliverable. We start with the facility or the standard under the most pressure and prove the route before you commit at scale.
Yes. Design, construction and management are aimed at international accreditation, backed by a proven track record of accreditations and reaccreditations in sub-Saharan Africa, a region where accreditation is scarce.
Reliable clean water treatment and on-site energy are built into the facility, so clinical care and accreditation do not depend on a public supply that may not be reliable.
Yes. It is effective against antimicrobial-resistant and biofilm-forming pathogens, with independently verified removal of 99.99% of biofilm and waterborne pathogens eliminated to 0 cfu/g under accredited testing.
Yes. Facilities are built to the IFC Performance Standards on pollution prevention and community health that development finance is conditional on, supporting bankability.
No. A single accountable partner carries both the technical delivery and the local execution, so capability is not assembled from a dozen sources against a financing deadline.
Tell us the capacity gap, the accreditation goal or the financing standard you are facing. We will set out the route, in confidence, before you commit at scale.
Tell us the cost, the risk or the obligation you are facing. A senior member of our team will respond, in confidence, with how we would help.
